Table 2. Correlation coefficients of CTLFA in all participants and separately in males, and females.
All participants | Males | Females | |
---|---|---|---|
Age, y | 0.26 ‡ | 0.25 ‡ | 0.27 † |
BMI, kg/m2 | -0.61 ‡ | -0.63 ‡ | -0.58 ‡ |
Neck circumference, cm | -0.41 ‡ | -0.35 ‡ | -0.55 ‡ |
Waist circumference, cm | -0.55 ‡ | -0.54 ‡ | -0.56 ‡ |
Systolic blood pressure, mm Hg | -0.17 † | -0.17 † | -0.20 |
Diastolic blood pressure, mm Hg | -0.22 ‡ | -0.21 † | -0.27 † |
Alcohol intake, g/d | -0.02 | -0.02 | 0.16 |
§ Use of lipid-lowering agents | -0.05 | -0.13 * | 0.12 |
§ Current smoking | -0.12 * | -0.12 | -0.08 |
VFA, cm2 | -0.49 ‡ | -0.49 ‡ | -0.53 ‡ |
SFA, cm2 | -0.49 ‡ | -0.59 ‡ | -0.43 ‡ |
AHI, h-1 | -0.21 ‡ | -0.29 ‡ | -0.01 |
4%ODI, h-1 | -0.24 ‡ | -0.29 ‡ | -0.09 |
%T90, % | -0.26 ‡ | -0.31 ‡ | -0.11 |
Lowest SpO2 during sleep, % | 0.13 † | 0.20 † | -0.05 |
Arousal Index, h-1 | -0.03 | -0.04 | 0.03 |
REM sleep, % | -0.03 | 0.04 | -0.18 |
AHI during REM, h-1 | -0.22 | -0.33 ‡ | 0.04 |
Supine sleep time, % | 0.12 * | 0.06 | 0.28 † |
AHI in supine position, h-1 | -0.21 ‡ | -0.27 ‡ | -0.05 |
Epworth sleepiness scale score | -0.17 † | -0.16 † | -0.16 |
CRP, mg/dL | -0.30 ‡ | -0.28 ‡ | -0.34 † |
Triglycerides, mg/dL | -0.41 ‡ | -0.42 ‡ | -0.44 ‡ |
HDL-cholesterol, mg/dL | 0.36 ‡ | 0.38 ‡ | 0.33 † |
LDL-cholesterol, mg/dL | -0.13 † | -0.16 † | -0.06 |
Fasting plasma glucose, mg/dL | -0.22 ‡ | -0.22 † | -0.23 * |
HOMA-IR | -0.40 ‡ | -0.44 ‡ | -0.35 † |
*P <0.10
†P <0.05
‡P <0.001, which indicate variables entered into the multivariate regression analyses.
§Correlation coefficients of these variables are indicated by Spearman's ρ, and the others are indicated by Pearson's γ. CTLFA is negatively correlated with liver fat accumulation.
Abbreviations: CTLFA, CT values for liver; BMI, body mass index; VFA, visceral fat accumulation; SFA, subcutaneous fat accumulation; AHI, apnea-hypopnea index; ODI, oxygen desaturation index; %T<90, percentage of time spent with SpO2 below 90% to total sleep time; SpO2, oxygen saturation measured by pulse oximetry; REM, rapid eye movement; CRP, C-reactive protein; HOMA-IR, homeostasis model assessment of insulin resistance.